Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Ido Amit
09.02.2026
Brain & Behavior, Cancer, Personalized Medicine, Molecular and Cell Biology, Immunology, Disease, Drugs & Diagnostics
After transforming the treatment of blood cancers, the CAR-T approach developed at the Weizmann Institute is now showing promise in a mouse...
19.11.2025
A new class of immune-activating molecules awakens anti-tumor immunity by targeting the tumor’s own defenses
10.04.2025
Researchers in Prof. Ido Amit’s lab identify a gene that reprograms macrophages into cancer-promoting cells — and show how to switch it off
18.01.2024
Cancer, Immunology, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Diagnostic Techniques and Drugs
A new kind of immunotherapy, based on crosstalk between different immune cells, could pave the way for innovative treatments of cancer and...
27.04.2023
Identifying the cells producing the hormone EPO may lead to the development of new therapies for treating anemia resulting from kidney disease and...
04.04.2022
Personalized Medicine, Molecular and Cell Biology, Immunology, Disease, Drugs & Diagnostics, Genetics
Weizmann Institute of Science researchers, in collaboration with Hadassah and Rambam physicians, present a new roadmap for exploring poorly...
22.02.2021
Cancer, Personalized Medicine, Immunology, Disease, Drugs & Diagnostics, Diagnostic Techniques and Drugs
From bedside to bench and back: Researchers reveal a genetic signature that could help overcome drug resistance in some of the most aggressive...
27.11.2020
A postdoc talks about complicated research, living at the Institute and the joys of scientific outreach
26.10.2020
Gut microbes and host cells jointly contribute to the progression of this mostly incurable disease
30.07.2020
In a study in mice, the mother’s natural anti-viral proteins disrupted the development of neural circuits in the fetus
